New Delhi, Feb. 20 -- To fix accountability, the government is working on a plan to include the name of the person responsible for releasing a batch of medicines under the Drugs Rules, 1945, according to an official familiar with the matter.

This comes against the backdrop of growing complaints about counterfeit and substandard drugs circulating in the market. The Central Drugs Standard Control Organization (CDSCO) increased inspections in the domestic pharmaceutical market after India-made cough syrups were linked to the deaths of children in Gambia and Uzbekistan in 2022 and 2023.

Currently, under the Drugs Rules, 1945, there is a provision of mentioning the names of staff responsible for manufacturing and testing when the drug licens...